The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSLPE.L Regulatory News (SLPE)

  • There is currently no data for SLPE

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Estimated NAV at 31 July 2020

14 Aug 2020 07:00

RNS Number : 9674V
Standard Life Private Eqty Trst PLC
14 August 2020
 

Standard Life Private Equity Trust plc

Legal Entity Identifier (LEI): 2138004MK7VPTZ99EV13

 

14 August 2020

Standard Life Private Equity Trust plc ("SLPET" or "the Company") announces its estimated net asset value ("NAV") at 31 July 2020

· Estimated NAV at 31 July 2020 was 421.4 pence per share (estimated NAV at 30 June 2020 was 431.2 pence per share)

· Interim dividend of 3.3 pence per share paid on 31 July 2020

· SLPET received £2.7 million of distributions and paid £2.1million of drawdowns during the month of July

· Outstanding commitments of £456.8 million at 31 July 2020

SLPET's valuation policy for private equity funds and co-investments is based on the latest valuations reported by the managers of the funds and co-investments in which the Company has interests. In the case of SLPET's valuation at 31 July 2020, excluding new investments, 99.7% by value of the portfolio valuations were dated 31 March 2020.

Of the valuations dated 31 March 2020, 89.4% of the portfolio by value accounted for the initial impact of COVID-19. For 10.3% by value of the portfolio, these interests were adjusted downward by the Manager as the underlying managers had not reflected the initial impact of COVID-19 within their 31 March 2020 valuations.

The remaining 0.3% by value of the portfolio has also been adjusted downward by the Manager based on the valuation as at 31 December 2019, adjusted for subsequent cash flows. Valuation adjustments were based on the weighted average movement in the Company's portfolio.

 

Estimated NAV

At 31 July 2020, SLPET's estimated NAV was 421.4 pence per share (estimated net assets £647.8 million), representing a 2.3% per share decrease from the estimated NAV at 30 June 2020 of 431.2 pence per share (estimated net assets £663.0 million). The 9.8 pence decrease in NAV per share reflected losses arising primarily from a 0.9% depreciation in the euro versus sterling during July and the second interim dividend payment of 3.3 pence per share, which was paid on 31 July 2020. The cash cost of the second interim dividend was £4.9 million.

 

Drawdowns and distributions

SLPET received £2.7 million of distributions and paid £2.1 million of drawdowns during the month. The distributions received generated realised gains and income of £1.5 million.

 

Commitments

The Company had £456.8 million of outstanding commitments at 31 July 2020. The Manager believes that around £67.2 million of the Company's existing outstanding commitments are unlikely to be drawn.

 

Balance sheet and credit facility

The Company had cash and cash equivalents of £45.3 million. In addition, it is due £15.2 million of deferred consideration during the year from investments sold in 2019. It also has an undrawn £100 million syndicated revolving credit facility, provided by Citibank and Societe Generale, that expires in December 2024.

 

Update on COVID-19

The Manager continues to maintain regular communication with the private equity managers of the Company's investments and is closely monitoring the situation surrounding COVID-19. Whilst the initial impact on the Company has been reflected within the actual NAV at 31 March 2020, we expect COVID-19 to impact private equity valuations negatively during the remainder of the year, which could lead to further reductions in the Company's NAV. We also continue to anticipate a decrease in the level of distributions in the near-term.

The latest update from the Manager, which provides responses to frequently asked questions in relation to COVID-19, is available within the Latest News section of the Company website; www.slpet.co.uk.

 

Future announcements

The Company is expecting to announce its actual NAV at 30 June 2020 on or around 30 September 2020 and will announce its estimated NAV at 31 August 2020 at the same time. 

Additional detail about SLPET's NAV and investment diversification can be found on SLPET's website. Neither the contents of the Company's website nor the contents of any website accessible from hyperlinks on the Company's website is incorporated into, or forms part of, this announcement.

 

For further information please contact Alan Gauld at SL Capital Partners LLP (0131 372 2200)

Note:-

Standard Life Private Equity Trust plc is an investment company managed by SL Capital Partners LLP, the ordinary shares of which are admitted to listing by the UK Listing Authority and to trading on the Stock Exchange and which seeks to conduct its affairs so as to qualify as an investment trust under sections 1158-1165 of the Corporation Tax Act 2010. The Board of Standard Life Private Equity Trust plc is independent of Standard Life Aberdeen plc and Phoenix Group Holdings.

Valuation Methodology

Unquoted investments are stated at the directors' estimate of fair value and follow the recommendations of EVCA and BVCA. The estimate of fair value is normally the latest valuation placed on a fund or co-investment by its manager at the balance sheet date. The valuation policies used by the manager in undertaking that valuation will generally be in line with the joint publication from EVCA and BVCA, 'International Private Equity and Venture Capital Valuation guidelines'. Where formal valuations are not completed at the balance sheet date the last available valuation from the fund manager or co-investment lead is adjusted for any subsequent cashflows occurring between the valuation date and the balance sheet date. The Company's Manager may further adjust such valuations to reflect any changes in circumstances from the last manager's formal valuation date to arrive at the estimate of fair value, for example, where sales proceeds are available. Quoted investments are valued based on quoted prices as of the last day of the relevant period.

The Company intends to release regular estimated NAV updates around ten business days after each month end, while continuing to issue quarterly updates. A breakdown of SLPET's portfolio can be obtained in the latest monthly factsheet, which is published on SLPET's website at:

www.slpet.co.uk

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
NAVGPUWURUPUGAP
Date   Source Headline
16th Mar 20117:30 amRNSQuarterly Trading Statement
31st Jan 20113:54 pmRNSDirector/PDMR Shareholding
31st Jan 20113:53 pmRNSDirector/PDMR Shareholding
31st Jan 201111:50 amRNSTotal Voting Rights
31st Jan 201111:03 amRNSDirector/PDMR Shareholding
27th Jan 201111:03 amRNSAnnual Financial Report
26th Jan 20119:33 amRNSIssue of Equity
25th Jan 20114:08 pmRNSResult of AGM
25th Jan 20111:00 pmRNSInterim Management Statement
17th Jan 201111:28 amRNSDirector/PDMR Shareholding
6th Jan 20112:05 pmRNSCalculation of Script Dividend Reference Price
6th Jan 201111:28 amRNSQuarterly Disclosure
21st Dec 201011:07 amRNSDoc re. Annual Report
20th Dec 20104:26 pmRNSAnnual Information Update
8th Dec 20104:02 pmRNSDirector/PDMR Shareholding
6th Dec 20107:00 amRNSPreliminary Results for year to 30/09/10
2nd Dec 20102:30 pmRNSDirectorate Change
30th Nov 20107:00 amRNSRefinancing of debt facility
17th Nov 20109:20 amRNSDirector Declaration
4th Oct 20102:45 pmRNSQuarterly Disclosure
30th Sep 20105:30 pmRNSTotal Voting Rights
28th Sep 201010:46 amRNSApplication for Listing
22nd Sep 20107:00 amRNSInvestment update for quarter to 30 June 2010
10th Aug 201012:49 pmRNSInterim Management Statement
2nd Jun 201012:36 pmRNSHolding(s) in Company
28th May 20107:00 amRNSHalf Yearly Report
9th Apr 201012:46 pmRNSHolding(s) in Company
17th Mar 20107:00 amRNSTrading Statement
9th Feb 201011:40 amRNSDirector/PDMR Shareholding
8th Feb 201010:19 amRNSDirector/PDMR Shareholding
2nd Feb 20103:02 pmRNSDirector/PDMR Shareholding
1st Feb 201011:14 amRNSDirector/PDMR Shareholding
1st Feb 201011:12 amRNSDirector/PDMR Shareholding
1st Feb 201011:10 amRNSDirector/PDMR Shareholding
1st Feb 201011:06 amRNSTotal Voting Rights
27th Jan 20103:39 pmRNSResult of AGM
27th Jan 201012:13 pmRNSInterim Management Statement
27th Jan 201010:00 amRNSApplication for Listing
20th Jan 20109:47 amRNSHolding(s) in Company
14th Jan 201011:30 amRNSAnnual Financial Report
12th Jan 201010:39 amRNSAnnual Information Update
7th Jan 20104:41 pmRNSCalculation of scrip dividend reference price
5th Jan 201012:46 pmRNSQuarterly Disclosure
23rd Dec 200910:57 amRNSDirector/PDMR Shareholding - Replacement
17th Dec 20092:25 pmRNSDoc re. Annual Report and Circular
3rd Dec 200912:13 pmRNSDirector/PDMR Shareholding
3rd Dec 20097:00 amRNSPreliminary results for year to 30/9/09
18th Sep 20097:00 amRNSThird Quarter Trading Statement
29th Jul 20097:30 amRNSInterim Management Statement
8th Jul 20092:23 pmRNSDirectorate Change

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.